WallStSmart

Micron Technology Inc (MU)vsResMed Inc (RMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Micron Technology Inc generates 977% more annual revenue ($58.12B vs $5.40B). MU leads profitability with a 41.5% profit margin vs 27.5%. MU appears more attractively valued with a PEG of 0.23. MU earns a higher WallStSmart Score of 83/100 (A-).

MU

Exceptional Buy

83

out of 100

Grade: A-

Growth: 5.3Profit: 10.0Value: 10.0Quality: 8.5
Piotroski: 4/9Altman Z: 3.06

RMD

Strong Buy

70

out of 100

Grade: B

Growth: 6.7Profit: 9.5Value: 8.7Quality: 8.3
Piotroski: 6/9Altman Z: 4.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MUUndervalued (+61.5%)

Margin of Safety

+61.5%

Fair Value

$992.16

Current Price

$382.09

$610.07 discount

UndervaluedFair: $992.16Overvalued
RMDUndervalued (+14.4%)

Margin of Safety

+14.4%

Fair Value

$303.30

Current Price

$226.31

$76.99 discount

UndervaluedFair: $303.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MU6 strengths · Avg: 10.0/10
Market CapQuality
$446.05B10/10

Mega-cap, among the largest globally

PEG RatioValuation
0.2310/10

Growing faster than its price suggests

Return on EquityProfitability
39.8%10/10

Every $100 of equity generates 40 in profit

Profit MarginProfitability
41.5%10/10

Keeps 42 of every $100 in revenue as profit

Operating MarginProfitability
67.6%10/10

Strong operational efficiency at 67.6%

Altman Z-ScoreHealth
3.0610/10

Safe zone — low bankruptcy risk

RMD4 strengths · Avg: 9.5/10
Operating MarginProfitability
35.2%10/10

Strong operational efficiency at 35.2%

Altman Z-ScoreHealth
4.3410/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
25.7%9/10

Every $100 of equity generates 26 in profit

Profit MarginProfitability
27.5%9/10

Keeps 28 of every $100 in revenue as profit

Areas to Watch

MU1 concerns · Avg: 4.0/10
Revenue GrowthGrowth
2.0%4/10

2.0% revenue growth

RMD0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : MU

The strongest argument for MU centers on Market Cap, PEG Ratio, Return on Equity. Profitability is solid with margins at 41.5% and operating margin at 67.6%. PEG of 0.23 suggests the stock is reasonably priced for its growth.

Bull Case : RMD

The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.5% and operating margin at 35.2%. Revenue growth of 11.0% demonstrates continued momentum.

Bear Case : MU

The primary concerns for MU are Revenue Growth.

Bear Case : RMD

No major red flags identified for RMD, but monitor valuation.

Key Dynamics to Monitor

MU profiles as a value stock while RMD is a mature play — different risk/reward profiles.

MU carries more volatility with a beta of 1.54 — expect wider price swings.

RMD is growing revenue faster at 11.0% — sustainability is the question.

MU generates stronger free cash flow (6.5B), providing more financial flexibility.

Bottom Line

MU scores higher overall (83/100 vs 70/100), backed by strong 41.5% margins. Both earn "Exceptional Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Micron Technology Inc

TECHNOLOGY · SEMICONDUCTORS · USA

Micron Technology, Inc. is an American producer of computer memory and computer data storage including dynamic random-access memory, flash memory, and USB flash drives. It is headquartered in Boise, Idaho.

Visit Website →

ResMed Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Visit Website →

Want to dig deeper into these stocks?